antibiotics

Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.

LIVE August 30th, 2021 at 1:30 PM ET

In this webinar, researchers will discuss new bacteriophage approaches to fight antibiotic-resistant microbes.

Phase 1/2 trial will assess safety and efficacy of RECCE 327 against broad range of infectious diseases on chronic burn wounds

The AMR Action Fund seeks to support antibiotic candidates in massive industry-philanthropic alliance